The Mirasol TM PRT system for pathogen reduction of platelets and plasma:: An overview of current status and future trends

被引：159

作者：

Goodrich, Raymond P.

Edrich, Richard A.

Li, Junzhi

Seghatchian, Jerard

机构：

[1] Navigant Biotechnol Inc, Lakewood, CO 80215 USA

[2] Blood Components Technol & Haemostasis Thrombosis, London NW3 3AA, England

来源：

TRANSFUSION AND APHERESIS SCIENCE | 2006年 / 35卷 / 01期

关键词：

riboflavin; pathogen inactivation; blood safety; transfusion medicine;

D O I：

10.1016/j.transci.2006.01.007

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

The safety of blood transfusion is still threatened by contamination of blood products with a variety of pathogens such as viruses, bacteria and parasites. A novel pathogen reduction process for platelets and plasma products, the Mirasol PRT system, has been developed and is under clinical evaluation for its efficacy and safety. The Mirasol PRT process is based on riboflavin photochemistry. This manuscript reviews current progress and future trends. (c) 2006 Elsevier Ltd. All rights reserved.

引用

页码：5 / 17

页数：13

共 53 条

[1]

Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction [J].